新生血管性年龄相关性黄斑变性抗血管内皮生长因子治疗后的早期与晚期视网膜色素上皮撕裂
本研究基于前瞻性设计的观察性数据库进行病例对照分析,纳入2006年1月至2017年1月期间开始抗VEGF治疗的初治新生血管性年龄相关性黄斑变性眼。55例发生视网膜色素上皮撕裂的病例与165只匹配对照眼进行比较,按分段回归模型将撕裂分为早期(182天前,38/55眼)和晚期(182天后,17/55眼)。早期撕裂眼在撕裂前视力改善,撕裂后立即下降,但12和24个月时与对照眼无差异;晚期撕裂眼撕裂前视力已显著低于对照眼,撕裂后未显著下降但持续低于对照眼。
要点
- 分段回归模型估计视网膜色素上皮撕裂时间断点为182天,早期撕裂占69%(38/55眼),晚期撕裂占31%(17/55眼)。
- 早期撕裂眼基线视力显著低于晚期撕裂眼(53.6 vs 63.4个字母,P=0.009)。
- 早期撕裂眼撕裂前视力较基线提高5.6个字母(P=0.01),撕裂后立即下降8.3个字母(P=0.002),12和24个月时与对照眼无差异(P>0.05)。
核心结论
- 视网膜色素上皮撕裂的表现取决于发生时机,长期视力结局可能与患者对治疗的反应相关而非撕裂本身。
研究设计与样本
- 前瞻性设计的观察性数据库(Fight Retina Blindness!研究)的病例对照分析。
- 纳入2006年1月至2017年1月期间开始抗VEGF治疗的初治新生血管性年龄相关性黄斑变性眼。
- 55例发生视网膜色素上皮撕裂的病例眼与165只对照眼按年龄、基线视力、病灶大小、撕裂前治疗时长和随访时长匹配。
主要发现
- 分段回归模型估计撕裂时间断点为182天,早期撕裂(断点前)38/55眼(69%),晚期撕裂(断点后)17/55眼(31%)。
- 早期撕裂眼基线视力显著低于晚期撕裂眼(53.6 vs 63.4个字母,P=0.009)。
- 早期撕裂眼撕裂前视力较基线提高5.6个字母(P=0.01),撕裂后立即下降8.3个字母(P=0.002),12和24个月时与对照眼无差异(P>0.05)。
- 晚期撕裂眼撕裂前视力显著低于对照眼(55.5 vs 66.9个字母,P<0.001),撕裂后未显著下降但所有终点持续低于对照眼。
- 早期和晚期撕裂眼在撕裂后接受的注射次数均多于对照眼。
关键数值与推荐
- 早期撕裂定义为182天断点前发生撕裂,晚期撕裂定义为182天断点后发生撕裂。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate when retinal pigment epithelium (RPE) tears occur and their associated treatment patterns and long-term visual outcomes in patients with neovascular age-related macular degeneration (nAMD) during anti-vascular endothelial growth factor (VEGF) treatment. DESIGN: Case-control analysis from a prospectively designed observational database. PARTICIPANTS: Treatment-naïve eyes enrolled in the Fight Retina Blindness! observational study that commenced anti-VEGF treatment for nAMD between January 2006 and January 2017 were identified. Cases were defined as eyes in which an RPE tear developed during treatment. Three control eyes per case were matched for age, baseline visual acuity (VA), lesion size, treatment duration before tearing, and duration of follow-up. METHODS: Cases were classified as having early or late tears using a segmented regression model. Baseline characteristics were compared between the 2 groups. Comparisons of VA and injections received between tear eyes and control eyes were performed at baseline, before and immediately after the tear, and then 12 and 24 months later. Visual acuity also was compared among different visits within each group. MAIN OUTCOME MEASURES: Visual acuity, time to tear, and injections received. RESULTS: Fifty-five cases and 165 matched control eyes were included. The segmented regression estimated a breakpoint for the time to tear at 182 days. We therefore defined eyes as having early tears if they tore before the breakpoint (38/55 eyes [69%]), and as late tears if they tore afterward (17/55 eyes [31%]). Baseline VA was significantly lower in early compared with late tears (53.6 vs. 63.4 letters; P = 0.009). Visual acuity had improved in early tears before the tear (+5.6 letters from baseline; P = 0.01), decreased immediately after the tear (-8.3 letters; P = 0.002), then recovered with no difference compared with control eyes 12 and 24 months later (P > 0.05 for both). Late tear eyes had significantly lower VA than control eyes before tearing (55.5 vs. 66.9 letters; P < 0.001). Visual acuity did not decrease significantly after the tear, but continued to decline compared with control eyes at all end points. Both early and late tear eyes received more injections than control eyes after tearing. CONCLUSIONS: Retinal pigment epithelium tears act differently depending on when they occur. Long-term visual outcomes in eyes affected by RPE tearing may be related more to the patient's response to therapy than to the tear itself.
引用
- Invernizzi A, Nguyen V, Arnold J, et al. Early and Late Retinal Pigment Epithelium Tears after Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2017. PMID: 28993010. doi:10.1016/j.ophtha.2017.08.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。